Covered recipient · General Payments record
SRINIVASAN RAGHAVAN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,559.33
- Reported across 83 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $430.28 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $188.50 | 8 |
| Cook Medical LLC | $97.18 | 1 |
| Amgen Inc. | $40.57 | 2 |
| Novo Nordisk AS | $37.19 | 2 |
| Phathom Pharmaceuticals, Inc. | $32.89 | 2 |
| Exact Sciences Corporation | $20.19 | 1 |
| GlaxoSmithKline, LLC. | $13.76 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $34.60 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105349276 | CMS |
| ABBVIE INC. | $31.24 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105349281 | CMS |
| ABBVIE INC. | $12.69 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105349284 | CMS |
| ABBVIE INC. | $19.92 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105349289 | CMS |
| ABBVIE INC. | $17.90 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105349293 | CMS |
| ABBVIE INC. | $3.67 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105349297 | CMS |
| ABBVIE INC. | $33.50 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105349301 | CMS |
| ABBVIE INC. | $34.98 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105349305 | CMS |
| Amgen Inc. | $19.13 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117661235 | CMS |
| Amgen Inc. | $21.44 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117661237 | CMS |
| Cook Medical LLC | $97.18 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118344575 | CMS |
| Exact Sciences Corporation | $20.19 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114844870 | CMS |
| GlaxoSmithKline, LLC. | $13.76 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116578206 | CMS |
| Novo Nordisk Inc | $19.64 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096811183 | CMS |
| Novo Nordisk Inc | $17.55 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097671794 | CMS |
| Phathom Pharmaceuticals, Inc. | $17.78 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151113204 | CMS |
| Phathom Pharmaceuticals, Inc. | $15.11 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151113206 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.